- Home
- CDNA vs TRIN Comparison
CDNA vs TRIN Comparison
Compare CDNA & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- TRIN
- Stock Information
- Founded
- CDNA 1998
- TRIN 2007
- Country
- CDNA United States
- TRIN United States
- Employees
- CDNA N/A
- TRIN N/A
- Industry
- CDNA Medical Specialities
- TRIN Finance/Investors Services
- Sector
- CDNA Health Care
- TRIN Finance
- Exchange
- CDNA Nasdaq
- TRIN Nasdaq
- Market Cap
- CDNA 1.0B
- TRIN 912.3M
- IPO Year
- CDNA 2014
- TRIN 2021
- Fundamental
- Price
- CDNA $18.85
- TRIN $14.04
- Analyst Decision
- CDNA Buy
- TRIN Hold
- Analyst Count
- CDNA 6
- TRIN 3
- Target Price
- CDNA $30.33
- TRIN $14.83
- AVG Volume (30 Days)
- CDNA 959.0K
- TRIN 874.7K
- Earning Date
- CDNA 07-30-2025
- TRIN 08-06-2025
- Dividend Yield
- CDNA N/A
- TRIN 14.54%
- EPS Growth
- CDNA N/A
- TRIN 37.77
- EPS
- CDNA 1.07
- TRIN 2.19
- Revenue
- CDNA $346,421,000.00
- TRIN $240,010,000.00
- Revenue This Year
- CDNA $13.31
- TRIN $24.11
- Revenue Next Year
- CDNA $15.46
- TRIN $4.87
- P/E Ratio
- CDNA $17.58
- TRIN $6.41
- Revenue Growth
- CDNA 25.92
- TRIN 30.65
- 52 Week Low
- CDNA $14.09
- TRIN $12.50
- 52 Week High
- CDNA $34.84
- TRIN $16.82
- Technical
- Relative Strength Index (RSI)
- CDNA 51.86
- TRIN 39.26
- Support Level
- CDNA $18.64
- TRIN $13.76
- Resistance Level
- CDNA $19.84
- TRIN $14.58
- Average True Range (ATR)
- CDNA 0.80
- TRIN 0.23
- MACD
- CDNA -0.07
- TRIN -0.03
- Stochastic Oscillator
- CDNA 25.60
- TRIN 30.39
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About TRIN Trinity Capital Inc.
Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.